Harmony Biosciences adds $15M incremental senior secured term loan

Harmony Biosciences Holdings, Inc.

Incremental Term Loan of $15M advanced on Sept 21, 2023; total term loans outstanding now $200M.
Proceeds used to pay transaction fees and for general corporate purposes.
Loan matures July 26, 2028; interest at Term SOFR + 3.5%-4% or base rate + 2.5%-3%.
Bank of America, N.A. served as incremental lender; JPMorgan Chase as administrative agent.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Harmony Biosciences Holdings, Inc. amended First Incremental Amendment with Bank of America, N.A. valued at $15 million (effective 2023-09-21).

Action: amendment
Agreement: credit facility
Counterparty: Bank of America, N.A.
Value: $15 million
Effective: 2023-09-21

Exact text from the filing

On September 21, 2023 (the "Closing Date"), the Company, as borrower, entered into the First Incremental Amendment (the "First Incremental Amendment") with the Administrative Agent and Bank of America, N.A., as incremental lender. The First Incremental Amendment provides for an incremental senior secured term loan (the "Incremental Term Loan") in an aggregate principal amount of $15 million

View on SEC.gov

Browse all material agreements →

Harmony Biosciences Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-015961

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.